Ad copy

5 Questions Your Urologist Can’t Answer About Tamsulosin. Ask Them At Your Next Appointment And See What Happens. Most Aussie blokes on Tamsulosin have never asked these questions. They just take the pills. They accept the dose increases. They wait for the next appointment and nod when the GP says everything's on track. Then one day they end up in the emergency department at 3am with a catheter and a bag strapped to their leg wondering how it got to this. A board-certified urologist with 25 years’ experience published an article last year that’s making the entire prostate medication industry pretty uncomfortable. Because he laid out five questions every patient on Tamsulosin should be asking. And explained why almost no GP or urologist can answer them without admitting something very inconvenient about how BPH is actually being treated. Here are the five questions. Ask them. See what happens. Question One. If Tamsulosin treats my prostate, why has my prostate kept growing while on the medication? This is the question that ends most consultations in under ninety seconds. Tamsulosin is an alpha blocker. It relaxes the smooth muscle around your urethra, easing pressure for 10 to 12 hours each dose, then it wears off. It doesn’t slow prostate growth. It doesn’t reduce prostate size. It doesn’t interact with the mechanisms causing your prostate to expand year after year. Your prostate can grow 30, 40, even 50 percent larger while you’re taking Tamsulosin daily and the medication won’t do a thing about it. When your GP says the medication’s working, what they mean is that muscle relaxation is compensating for the growing pressure. For now. Eventually the pressure overwhelms the muscle relaxation. That’s when the dose goes up. That’s when Finasteride gets added. That’s when the letter arrives suggesting a surgical consult. Ask the question. Watch the pause. Question Two. Why does the dose keep increasing if the medication is actually working? A medication that works doesn’t need to be boosted. Your blood pressure meds don’t get stronger every year. Your statins don’t require higher doses. Tamsulosin does, because it’s not treating the root cause. It’s managing a symptom while the condition worsens. The 2018 European study every urologist has tucked away showed 57 percent of men on Tamsulosin for five or more years needed surgery anyway. More than half. The meds buy time. Not a fix. Your GP might say "expected progression." That phrase does a lot of work. It really means: the medication’s losing ground, so we push harder on the same lever that doesn’t solve the problem. Expected progression isn’t success. It’s failure normalised. There’s a reason it sounds reassuring. The health system needs something to calm patients while handing over higher doses or a second drug. Expected progression turns failure into a milestone, escalating doses into a treatment plan. A medication needing raises, combos, or replacement isn’t treating the condition. It’s chasing it. Eventually the condition outruns the meds. Ask the question. Notice what words they use. Question Three. What causes retrograde ejaculation and why wasn’t I warned before my first script? Retrograde ejaculation is when semen goes backward into the bladder during orgasm rather than out. Nothing or almost nothing comes out. A common side effect of long-term Tamsulosin use. It’s listed on consent leaflets between dizziness and stuffy nose, as if they belong in the same category. Dizziness passes. Stuffy nose passes. Retrograde ejaculation becomes a permanent part of your intimate life, often without your partner knowing why the bloke she’s been with for 30 years now turns away at night. One bloke said Tamsulosin destroyed his sex life after 15 years. Another quit Finasteride within three months—losing 80 percent of his ejaculate and called it disturbing. He picked urinating 18 times a day over the drug. Ask your GP why this wasn’t explained clearly before starting. Ask what the medication does at the bladder neck to cause this. Ask if it reverses when you stop. The answer might be technical—something about muscle relaxation and seminal vesicle contraction. But what’s not said is how this side effect quietly reshapes a man’s intimate life, rarely talked about and almost never flagged as grounds to reconsider treatment. Men often don’t tell their GP or partner. They just adjust—turning away, making excuses. Distance grows slowly until the scale of loss hits after three to five years on medication. This is the part of the Tamsulosin story missing from any leaflet. It’s the part men who’ve lived it want every new patient to understand before the first pill. Listen carefully to the answer. Question Four. If 31 percent of TURP patients need another procedure within ten years, what exactly is surgery fixing? This question silences the room. It shifts the consultation from conversation to discomfort. Because surgery is offered not as a cure, but a temporary fix for a progressive issue. A cure wouldn’t have a 31 percent recurrence rate in ten years. A cure is a cure. Surgery removes tissue pressing on the urethra; the stream returns, pressure drops—just for a while. It doesn’t stop DHT overproduction, clear hormonal waste clogging blood vessels, or resolve chronic inflammation. The three mechanisms driving prostate growth keep running post-surgery. That’s why 31 percent need another procedure within ten years. The tissue grows back because nothing stopped the cause. And surgery’s cost goes well beyond $14,000 to $18,000 AUD privately. Retrograde ejaculation becomes permanent for nearly all TURP patients. Erectile dysfunction affects 45 to 70 percent. Permanent incontinence requiring pads hits 15 to 20 percent. 52 percent regret having the surgery. Ask your urologist what exactly the surgery is fixing—not removing. Watch the pause. Question Five. Why aren’t natural compounds at clinical doses prescribed when published research shows they address all three root causes simultaneously? This question ends the appointment. No one holds a patent on Quercetin. Nor Saw Palmetto, Beta Sitosterol, French Maritime Pine Bark or Curcumin. Pharma can’t patent nature. No profit in your prostate healing naturally. Money’s in prescriptions, dose increases, Finasteride additions, and surgery costing upwards of $14,000 AUD privately. The prostate supplement market is unregulated and full of underdosed products giving the sector a bad name. So patients get pushed toward revenue-generating meds while compounds proven to address root causes sit on shelves at ineffective doses. This isn’t a conspiracy. It’s a financial incentive structure pointing one way. Ask your urologist why clinically dosed Quercetin at 400 mg, Saw Palmetto at twice standard dose, Beta Sitosterol supported by The Lancet, plus seven other peer-reviewed compounds aren’t offered before Tamsulosin, Finasteride or surgery. He might not have an answer — and that’s the answer. Training, protocols, drug reps don’t cover it. The system delivers standard care with approved, patented, commercially distributed tools. Natural compounds at clinical doses aren’t part of it because there’s no commercial model. So they remain on shelves at wrong doses, marketed by companies without clinical trials, sold to patients who can’t verify ingredients match research. One clinically dosed compound is interesting. Ten compounds targeting three mechanisms at once is a formulation — and such a formulation doesn’t exist in the pharmaceutical pathway due to lack of revenue. This is the gap Dr Thompson aimed to close. He did something rare for a urologist — spent six months reading peer-reviewed journals outside his specialty: biochemistry, nutrition, cell biology of inflammation. He merged existing research in ways pharma wouldn’t, producing a clinical dose protocol addressing all three mechanisms: DHT, vascular, nutrient — with compounds and doses supported by published literature. The Urologist Who Could Answer All Five Questions. After 25 years performing surgery, prescribing meds and watching men escalate from 0.4 mg Tamsulosin to a 3am catheter, Dr Michael Thompson mined clinical trials — not supplement hype or blogs — from respected journals like Urology, The Lancet, and BJU International. He identified ten compounds, all at research-backed doses: Quercetin 400 mg dissolving hormonal waste, Saw Palmetto 320 mg regulating DHT, Beta Sitosterol 100 mg improving flow, French Maritime Pine Bark reopening prostate blood vessels, Curcumin tackling inflammation & DHT, plus Grape Seed Extract, Pygeum, Pumpkin Seed, Lycopene, Rye Pollen Extract. Ten ingredients total, addressing all three root causes together. He combined them into a formula called EaseFlow. Men who tried it reported sleeping past 5am in the first week, stronger flow by week three, measurable improvements at their next urology visit. One man’s flow jumped from 7 ml/sec to 16 in 30 days; residual volume dropped from 155 ml to 28, and surgery was cancelled. Another was told TURP was needed. He refused. Within 30 days his flow doubled and his urologist couldn’t explain it by meds alone. A third summed up its impact: “I can sit through a meal again.” Not about stats, just sitting with his wife and daughter, eating dessert without planning toilet breaks or excuses. His wife said it differently: “He’s back.” That’s what men on the other side keep saying — some version of ‘back.’ Back from meds, silence, the isolating shrinking world, the so-called expected progression that was just failure in disguise. The clinical numbers matter: flow rate doubled, residual volume down 80%, sleep through the night, surgery cancelled. But what keeps appearing in men’s notes isn’t on any printout: time. Hours. An evening without a bathroom stop. A drive to the coast no service station breaks. A Saturday morning with no toilet struggle. A night reaching for a wife he’d stopped reaching for. Time returned. That’s what these compounds quietly give men back. EaseFlow comes with a 60-day money-back guarantee. No questions asked, even on empty bottles. A limited-time deal is running on their website. Two Paths From Here. The first is where you are: Tamsulosin, maybe Finasteride, dose rises year after year, retrograde ejaculation without consent, weaker streams despite daily meds, a catheter at 3am, surgical referrals, TURP, permanent ejaculation loss for nearly all, 45 to 70 percent erectile dysfunction, 15 to 20 percent permanent incontinence, 31 percent needing a second procedure due to tissue regrowth, 52 percent regret. This path escalates. The second is what men who asked the five questions found: ten clinical dose compounds, all three root causes tackled, no patent, no profit motive blocking it, just published research and a formulator who refused to accept the same failing escalation after seeing his own prostate grow 40% beyond normal. Ask the five questions at your next appointment, or read the full answers and clinical research now. See the full list. Decide for yourself before the next dose increase, referral, or a 3am catheter. Most men won’t ask. They’ll nod, close the tab, and refill the prescription like the system expects — trusting the script more than their own questions. The men who break free read the full article, see the research, understand the compounds and doses, and give themselves permission to try something before the next dose increase takes over. Read the full list now. While there’s still time to change your path.